Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Persian Gulf Newswire.
Press releases published on August 28, 2025
More Antimony Assays Reported at Bald Hill Project
GlobeNewswire
·
August 28, 2025
ROUYN-NORANDA, Quebec, Aug. 28, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang …
"Birds of Prey" Weaponized Drone System Marketed Through Duke Robotics’ Collaboration with Elbit Featured On Israeli Television Segment
GlobeNewswire
·
August 28, 2025
FT. LAUDERDALE, FL, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Duke Robotics Corp. (OTCQB: DUKR) ("Duke Robotics" or the "Company"), a leader in advanced robotics technology and autonomous drone solutions, today announced that the "Birds of Prey" stabilized weapons …
Codexis to Participate in Cantor Global Healthcare Conference
GlobeNewswire
·
August 28, 2025
REDWOOD CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend the Cantor Global …
Oncotelic Therapeutics Showcases Robust Pipeline and Founder’s Broad Intellectual Property Contributions to Biopharma Industry
GlobeNewswire
·
August 28, 2025
Highlighting multibillion-dollar drug discoveries and advancing novel oncology and immunotherapy assets AGOURA HILLS, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“OTLC” or the “Company”), a clinical stage …
Can-Fite Reports H1 2025 Financial Results and Clinical Update
GlobeNewswire
·
August 28, 2025
Ramat Gan, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today …
Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss
GlobeNewswire
·
August 28, 2025
Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s continued commitment to its complex generic medicine portfolio …
ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Pioneering Innovative Mining Approach, Demonstrating Next-Gen Processing Capabilities
GlobeNewswire
·
August 28, 2025
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN ( …
Aprea Therapeutics to Present at H.C. Wainwright Global Investment Conference
GlobeNewswire
·
August 28, 2025
DOYLESTOWN, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while …
CorMedix to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 28, 2025
BERKELEY HEIGHTS, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (“CorMedix”) (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced …
Alarum Technologies Announces Second Quarter 2025 Results
GlobeNewswire
·
August 28, 2025
Deepening collaborations with major global customers while accelerating investments in technology and talent to cement Alarum’s key positioning in the AI value chain Q2 2025 revenues of $8.8 million, net profit of $0.3 million, and Adjusted EBITDA of $1.0 …
Round and Large Wall Mirrors Shape 2025 Interior Design Trends in Dubai
EIN Presswire
·
August 28, 2025
Round and Large Wall Mirrors Shape 2025 Interior Design Trends in Dubai DUBAI, AL MANARA, UNITED ARAB EMIRATES, August 28, 2025 /EINPresswire.com/ -- Mirrors have become essential elements of modern interiors. They combine functionality with aesthetic …
Kyverna Therapeutics Highlights Neuroimmunology CAR T Franchise and Registrational Phase 3 Trial Design in Myasthenia Gravis at Virtual KOL Event
GlobeNewswire
·
August 28, 2025
KYV-101 has the potential to deliver durable, drug-free, disease-free remission in myasthenia gravis and set a new treatment standard for stiff person syndrome Innovative FDA-aligned KYSA-6 Phase 3 trial design for myasthenia gravis supports clear and …
CTERA Survey Finds Cybersecurity and Cost Take Priority in 2025, as AI Ambitions Outpace Readiness
GlobeNewswire
·
August 28, 2025
New York, NY, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CTERA, the leader in Integrated Data Intelligence, today unveiled insights from its 2025 State of Data and Cloud Strategy Survey Report. The findings highlight that a promising 57% of IT and cybersecurity …
Fancamp Exploration Announces Grant of Stock Options
GlobeNewswire
·
August 28, 2025
VANCOUVER, British Columbia, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Fancamp Exploration Ltd. (“Fancamp” or the “Corporation”) (TSX Venture Exchange: FNC) announces that it has granted stock options (“Options”) to its directors and officers, pursuant to the …
NevGold Announces Entry Into Standstill With GoldMining
GlobeNewswire
·
August 28, 2025
Vancouver, British Columbia, Aug. 28, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce that it has entered into a standstill agreement with GoldMining Inc. (“GoldMining”), …
Entera Bio to Unveil Clinical and Non-Clinical Data Across 3 Oral Peptide Programs at Upcoming September Conferences
GlobeNewswire
·
August 28, 2025
Osteoporosis Program: Phase 2 analysis exploring the dual actions of oral PTH(1-34) tablet treatment, EB613 on trabecular and cortical bone, and Next-Gen EB613 PK/PD data slated for oral and poster presentations at ASBMR Short Bowel Syndome and Rare GI …
Crescent Biopharma to Present at September Investor Conferences
GlobeNewswire
·
August 28, 2025
WALTHAM, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management …
Koryx Copper Announces Further Drill Assay Results Extending Consistent Mineralization at Depth and Laterally at the Haib Copper Project, Southern Namibia
GlobeNewswire
·
August 28, 2025
Highlights • Completed a further 7 drill holes for 2,986m out of a planned 178 holes in Phase 2, 3 and 4. • 15,349m of the 28,000m drill target for 2025 has been completed to date. • Drill results extended mineralization into some areas previously modelled …
Outlook Therapeutics Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD
GlobeNewswire
·
August 28, 2025
FDA issues Complete Response Letter (CRL) for resubmitted ONS-5010 BLA Outlook Therapeutics plans to work with FDA to address the Agency’s issues Company to host a conference call and webcast today, August 28th at 8:30 AM ET ISELIN, N.J., Aug. 28, 2025 ( …
Azimut découvre une nouvelle zone aurifère à haute teneur sur Wabamisk, région de la Baie James, Québec
GlobeNewswire
·
August 28, 2025
Zone Rosa définie en surface sur 700 m de long au minimum avec des teneurs en or élevées et consistantes sur 300 m Suivi intensif en cours, préparatoire aux forages LONGUEUIL, Québec, 28 août 2025 (GLOBE NEWSWIRE) -- Exploration Azimut Inc. (« Azimut » ou …